C-TNMCMitotech
mitochondrial protection, oxidative stress, small molecules
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-TNMC
C-TNMCC-TNMCmitochondrial protection, oxidative stress, small molecules
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Mitotech mitochondrial protection, oxidative stress, small molecules
Mitotech focuses on protecting mitochondria from oxidative stress and enhancing energy expenditure. The company is developing orally bioavailable small molecules that could restore mitochondrial function and offer therapeutic options for rare mitochondrial, metabolic, autoimmune, cardiovascular, and neurodegenerative diseases.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Mitotech — Near-term readout · Lower middle. Derived deterministically from 1 extracted project(s). Most-advanced status: approved. Band: near_readout. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic